Banasthali University, Rajasthan

Jawaharlal Nehru Technical University, Hyderabad

Torrent Pharmaceuticals

Opening for Scientist in F&D

National AIDS Research Institute, Pune

Summer Project Training

USV

Post for Project Executive

Tuticorin Port Trust

Pharmacist requirement

JAMIA HAMDARD

Torrent Pharmaceuticals

Job as Medical Representative

Europa Healthcare

 The National Institutes of Health (NIH) announced that it is creating a public database that researchers, consumers, health care providers, and others can search for information submitted voluntarily by genetic test providers. The Genetic Testing Registry (GTR) aims to enhance access to information about the availability, validity, and usefulness of genetic tests.

A two-day symposium on clinical trial 'CLINICON 2010' will be held at Narayana Health City in Bangalore from March 26 to 27, 2010. The event will help bring together experts in the field of clinical research.

 The next Indian Pharmaceutical Association Convention (IPA Convention 2011) will be held at Indore in Madhya Pradesh in April next year. This was announced by the outgoing president of IPA Dr B Suresh at the valedictory session of the IPA Convention 2010 held in Chennai last week.

 Entailing the ongoing controversy over the recognition of Master of Pharmacy (MS) programme offered by National Institute of Pharmaceutical Education and Research (NIPER), Mohali, Pharmacy Council of India (PCI) has come out with a clarification that the NIPER's MS programme has not been specifically commented anytime by the council and is not an issue under the consideration of the body.

TTK Healthcare

Vacancy for Medical Representative

Torrent Pharmaceuticals

Job as Scientist

 March 23, 2010 (Atlanta, Georgia) — An unexplained bias against sending women to the cath lab may be the reason women are about twice as likely as men to die within a month of an MI, a study from the European Cardiology Audit and Registration Data Standards (CARDS) data set shows.

 Piramal Healthcare and Cipla signed a definitive agreement for purchase of all intellectual property rights in India related to i-pill brand of Cipla. The deal was sealed for an aggregate consideration of Rs 95 crore. i-pill brand features in the top-300 pharmaceutical products and had sales of Rs 30.92 crore as per ORG IMS for the last twelve months.

Even as the dust is yet to settle down over the HPV vaccine trial and death of three tribal girls in Andhra Pradesh, records showed that the total number of deaths among the clinical trial subjects, though not officially termed as part of the trials, are on the increase in India.